No Data
No Data
RedHill Biopharma Plans to File for UK Approval of H.Pylori Treatment
RedHill Biopharma Plans To Submit FDA Approved Talicia Used To Treat H. Pylori Infection For UK Marketing Approval
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
RedHill Biopharma Initiates Phase 2 Study Of RHB-204 In Mycobacterium Avium Subspecies Paratuberculosis-Positive Moderate To Severe CD
RedHill Biopharma Licenses RHB-102 to Hyloris for Global Markets